Clinical Trial Update: Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the longer-term efficacy and safety of sibutramine hydrochloride in obese subjects has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Sibutramine hydrochloride (sibutramine hydrochloride)

Snippet

Sponsor: Abbott | Conditions: Obesity, Weight Loss | Phase 3 | Status: TERMINATED